Early data suggest medicinal cannabis could treat prostate cancer

Just like in other fields of warfare, new technologies will have to be developed and new avenues explored to find new treatments.

Medicinal cannabis could be one of those avenues; in fact, it could become the government’s unexpected weapon in its war on cancer.

Data from a UK-based company, Apollon Formularies, has found that medicinal cannabis can kill prostate cancer cells.

In a statement, it said: “Medicinal cannabis formulations were shown to be effective in killing both hormone-resistant and hormone-sensitive prostate cancer cells in 3D cell cultures in third-party independent laboratory testing.”

Doctor Stephen Barnhill, CEO of Apollon, noted: “Cannabinoids have been seen to exert “antitumor” effects by a number of different means, including killing cancer cells directly as well as inhibiting cell growth and tumor metastasis.”

Although these results were conducted in a laboratory setting, they add to a growing body of evidence suggesting cannabis could have a positive impact on cancer and therefore play a role in future treatments.

Cannabis cancer research is catching up after years of stigmatization stifled research projects and trials.

As well as Apollon Formularies’ research, the Universities of Birmingham and Leeds are running a trial into whether a form of medicinal cannabis known as Sativex could be used to treat brain tumors.

[Original Source]